(PharmaNewsWire.Com, May 29, 2021 ) The ligation devices market is projected to reach USD 1,189 million by 2024 from USD 876 million in 2019, at a CAGR of 6.3% during the forecast period. Growth in this market is mainly driven by the increasing prevalence of diseases requiring surgical treatment,...
(PharmaNewsWire.Com, May 29, 2021 ) The vitamin D therapy market is projected to reach USD 3.3 billion by 2024 from USD 1.9 billion in 2019, at a CAGR of 11.6% during the forecast period. Growth in this market is largely driven by the growing awareness about vitamin D deficiency and the presence...
(PharmaNewsWire.Com, May 29, 2021 ) The osteoarthritis therapeutics market is projected to reach USD 11.0 billion by 2025 from USD 7.3 billion in 2020, at a CAGR of 8.7% from 2020 to 2025. The presence of a large geriatric and target patient population and the improving healthcare infrastructure...
(PharmaNewsWire.Com, May 31, 2021 ) The research study involves four major activities to estimate the current market size for the ELISpot and FluoroSpot market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate...
(PharmaNewsWire.Com, May 30, 2021 ) The research study involves four major activities in estimating the current market size for CRISPR technology. Exhaustive secondary research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate...
(PharmaNewsWire.Com, May 29, 2021 ) Major Market Growth Drivers:The major driving factors for Preparative Chromatography Market include increasing demand for insulin and other biopharmaceutical products, high demand for omega-3 fatty acids, and rising awareness about advancements in process and...
(PharmaNewsWire.Com, May 29, 2021 ) The global dental biomaterials market is projected to reach USD 9.6 billion by 2023 from USD 6.7 billion in 2018, at a CAGR of 7.4%. The growing prevalence of dental disorders, rising geriatric population, and the growing dental tourism in emerging countries are...
(PharmaNewsWire.Com, May 29, 2021 ) The apoptosis assays market is expected to reach USD 5.9 billion by 2023 from an estimated USD 3.6 billion in 2018, at a CAGR of 10.5%. The major factors driving the growth of this market include the rising incidence and prevalence of chronic and infectious diseases,...
(PharmaNewsWire.Com, May 29, 2021 ) The global laboratory mixers market size is projected to reach USD 2.1 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 3.7% during the forecast period growth in the laboratory mixers market is majorly driven by rising increasing research activity in...
(PharmaNewsWire.Com, May 29, 2021 ) The global HLA typing market is projected to reach USD 1.7 billion by 2025 from USD 1.2 billion in 2019, at a CAGR of 5.9%. Growth in the HLA typing market is mainly driven by factors such as the increasing number of HLA typing procedures conducted, technological...
(PharmaNewsWire.Com, May 31, 2021 ) The major factors driving the growth of the sleep apnea devices market are primarily a large pool of undiagnosed sleep apnea patients, growing awareness about the ill effects of untreated sleep apnea, growing usage of oral appliances, technological advancements...
(PharmaNewsWire.Com, May 31, 2021 ) Growth in this market is primarily driven by rising industry-academia collaborations, the increasing number of clinical trials, rising technology adoption, and government support for research trials. However, budget constraints and limited knowledge about advanced...
(PharmaNewsWire.Com, May 31, 2021 ) The major factors driving the growth of the air quality monitoring system market include the supportive government regulations for effective air pollution monitoring and control, ongoing initiatives towards the development of environment-friendly industries, increasing...
(PharmaNewsWire.Com, May 29, 2021 ) The benign prostatic hyperplasia treatment market is projected to reach USD 14.1 billion by 2026 from USD 10.8 billion in 2021, at a CAGR of 5.3% from 2021 to 2026.The growth of this market is driven by the increasing prevalence of benign prostatic hyperplasia,...
(PharmaNewsWire.Com, May 31, 2021 ) Factors such as the implementation of initiatives to shift the burden of risk from healthcare payers to providers, government initiatives and regulations promoting patient-centric care, initiatives to promote healthcare IT, rising geriatric population, and need...
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
